Wall Street analysts expect VWR Corporation (NASDAQ:VWR) to report $1.17 billion in sales for the current quarter, according to Zacks. Four analysts have made estimates for VWR Corporation’s earnings, with the lowest sales estimate coming in at $1.15 billion and the highest estimate coming in at $1.19 billion. VWR Corporation posted sales of $1.14 billion in the same quarter last year, which would indicate a positive year over year growth rate of 2.6%. The business is expected to announce its next earnings report on Thursday, November 2nd.

According to Zacks, analysts expect that VWR Corporation will report full year sales of $1.17 billion for the current fiscal year, with estimates ranging from $4.58 billion to $4.70 billion. For the next year, analysts anticipate that the firm will report sales of $4.79 billion per share, with estimates ranging from $4.74 billion to $4.86 billion. Zacks’ sales averages are a mean average based on a survey of research firms that that provide coverage for VWR Corporation.

VWR Corporation (NASDAQ:VWR) last announced its quarterly earnings data on Monday, July 31st. The medical research company reported $0.49 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.45 by $0.04. The business had revenue of $1.18 billion during the quarter, compared to analysts’ expectations of $1.16 billion. VWR Corporation had a return on equity of 15.54% and a net margin of 3.12%. The firm’s quarterly revenue was up 2.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.42 earnings per share.

Several brokerages have issued reports on VWR. TheStreet raised VWR Corporation from a “c” rating to a “b-” rating in a research report on Wednesday, April 19th. William Blair cut VWR Corporation from an “outperform” rating to a “market perform” rating in a research report on Friday, May 5th. Zacks Investment Research raised VWR Corporation from a “hold” rating to a “buy” rating and set a $37.00 target price on the stock in a research report on Tuesday, May 16th. Finally, BidaskClub cut VWR Corporation from a “hold” rating to a “sell” rating in a research report on Sunday, July 16th. Three investment analysts have rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company’s stock. VWR Corporation has an average rating of “Hold” and a consensus price target of $30.50.

Several hedge funds have recently bought and sold shares of VWR. SG Americas Securities LLC acquired a new stake in VWR Corporation during the second quarter worth $531,000. Capital Insight Partners LLC boosted its stake in VWR Corporation by 4.4% in the second quarter. Capital Insight Partners LLC now owns 46,748 shares of the medical research company’s stock worth $1,543,000 after buying an additional 1,962 shares during the last quarter. Exane Asset Management acquired a new stake in VWR Corporation during the second quarter worth $1,059,000. Aperio Group LLC boosted its stake in VWR Corporation by 84.4% in the second quarter. Aperio Group LLC now owns 49,608 shares of the medical research company’s stock worth $1,638,000 after buying an additional 22,712 shares during the last quarter. Finally, Public Employees Retirement System of Ohio boosted its stake in VWR Corporation by 3.4% in the first quarter. Public Employees Retirement System of Ohio now owns 31,762 shares of the medical research company’s stock worth $896,000 after buying an additional 1,031 shares during the last quarter.

ILLEGAL ACTIVITY WARNING: “VWR Corporation (NASDAQ:VWR) Expected to Post Quarterly Sales of $1.17 Billion” was originally reported by Daily Political and is the property of of Daily Political. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright laws. The original version of this piece can be viewed at https://www.dailypolitical.com/2017/08/06/vwr-corporation-nasdaqvwr-expected-to-post-quarterly-sales-of-1-17-billion.html.

VWR Corporation (VWR) opened at 33.00 on Friday. The stock has a market cap of $4.35 billion, a PE ratio of 30.56 and a beta of 1.19. VWR Corporation has a 52 week low of $24.42 and a 52 week high of $37.25. The firm’s 50-day moving average price is $32.99 and its 200-day moving average price is $29.83.

VWR Corporation Company Profile

VWR Corporation is a provider of product and service solutions to laboratory and production customers. The Company offers a portfolio of branded and private label laboratory products, services and solutions to the life science, general research and applied markets. The Company operates in two segments: Americas and EMEA-APAC.

Get a free copy of the Zacks research report on VWR Corporation (VWR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for VWR Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VWR Corporation and related companies with MarketBeat.com's FREE daily email newsletter.